Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Active Ankylosing Spondylitis (Phase II, China)
CTR20130153Phase 2Active
- Sponsor
- Changzhou Pharmaceutical Factory
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in ankylosing spondylitis (AS), sponsored by Changzhou Pharmaceutical Factory. Started Oct 2013; status: active.
02
Drugs
thalidomide
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on CTR20130153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130153.